Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Demystifying Artificial Intelligence in Rheumatology

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  Issue: July 2024  |  July 9, 2024

As of 2024, computers do not have the ability to empathize.7 Rather, they can create words that can provoke certain sensations and sentiments among humans. When an AI chatbot tells us how important it is to take allopurinol because it cares about a patient, we should be rightfully suspicious. Humans have the ability to develop social relationships with inanimate objects, and AI has been shown to have the capacity to be manipulative and deceptive.8 Without safeguards from humans, we are inviting AI to provide sociopathic care.

Implications of AI

Beyond ethical considerations, integrating AI into healthcare is not without its economic and environmental implications. AI does not exist isolated in a box, but is rather entwined with the natural world.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Running tools powered by AI is not without costs. Although the numbers are difficult to find, one report suggests that operating ChatGPT costs approximately $700,000 per day. Electricity, water (for cooling), rental costs and more are all part of these operating expenses. Currently, these costs are somewhat subsidized by investors who anticipate their AI products will become more profitable as they become ubiquitous, but there is no guarantee this will continue. In a healthcare system that already has exorbitant costs with unclear benefits, are we ready to become one of these investors?

This cost does not even address the environmental aspects of AI. Computers and computer systems are reliant upon rare earth metals. Mining these is extremely detrimental to the environment. Additionally, to power them, electricity must be derived from sources that may not necessarily be eco-friendly. And lastly, servers need to be cooled by water, an increasingly scarce resource. Worldwide, it may require 6.6 billion m3 of water by 2027 to operate AI servers. Strategies to mitigate these negative consequences are in dire need before we implement AI within an industry that comprises 18% of our national gross domestic product.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Thoughtful De-implementation

While we rush toward the idea of implementing something new, we always have to keep our eyes on de-implementing what is old. This de-implementation must be managed carefully to ensure we don’t contribute to bloat and system redundancy. With AI updates coming at an increasingly rapid rate, healthcare leaders must prioritize plans for de-implementation of obsolete models and technologies.

De-implementation is not easy, but it is essential for diversity, equity and inclusion considerations. Innovations rarely spread in an equitable manner, but rather diffuse within communities and societies. Not surprisingly, when a resource-intensive innovation, like AI, comes to the fore the communities that do not have free resources will be the last to obtain its benefits. This is why de-implementation is important: It places the onus of healthcare equity back on those who are most eager to implement, so they can think clearly and holistically about how their additions will necessarily lead to subtraction of care from others.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionRheuminations Tagged with:artificial intelligenceelectronic health records (EHRs)

Related Articles

    Ethics Forum: The Current Landscape of Artificial Intelligence in Medicine

    May 6, 2024

    A handful of articles on artificial intelligence (AI) have graced the pages of this publication in the past six years, including one by Bharat Kumar, MD, in November 2022. Dr. Kumar highlighted the exciting potential of AI in rheumatology, including machine learning (ML) algorithms for the prediction of response to methotrexate and a predictive model…

    Bharat Kumar, MD

    Exploring the Role of Artificial Intelligence in Rheumatology

    November 4, 2022

    I looked at the joints. They spoke back to me—”I need more humanism,” they whispered. To longtime readers, those two sentences may sound both familiar and alien, perhaps even a little humorous. That’s because those sentences were generated entirely by a computer using artificial intelligence (AI). It was simple, too: I just copied the text…

    Artificial Intelligence in Medicine: The Future Is Now

    August 26, 2020

    Advancements in technology and artificial intelligence designed to aid rheumatologists in diagnosing patients and predicting mortality risk were discussed in depth during a session of the European e-Congress of Rheumatology.

    TrifonenkoIvan / shutterstock.com

    Artificial Intelligence Gives Rheumatologists an Assist

    June 14, 2021

    As the novel coronavirus that causes COVID-19 spreads across the globe, innovative thinking is needed more than ever to counter the devastating effects on the physical and socioeconomic health of individuals and communities. Innovations in healthcare delivery not yet fully realized prior to the pandemic, such as the adoption of telehealth, are moving to the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences